The goal of the Reducing Cancer Disparities (RCD) Program is to develop and test the effectiveness of interventions to reduce cancer risk and modify behaviors among underserved populations in the MCC catchment area. This goal is accomplished through highly interactive teams of 18 faculty members from UCSD and SDSU that include expertise from the Departments of Family and Preventive Medicine, Surgery, and Psychiatry at UCSD, as well as the Graduate School of Public Health and Psychology Department at SDSU. RCD is organized into 3 thematic foci: Theme 1: Lifestyle factors in community-based studies; Theme 2: Tobacco cessation; Theme 3: Screening and early detection. In 2012, the Program had $9.1 million of peer reviewed research grant funding (annual direct costs), which includes $5.4 million from NCI. Members of RCD published 255 programmatically aligned articles since 2007; 20% were the result of intraprogrammatic collaborations and 25% were inter-programmatic. Significant accomplishments in the last grant period include: (i) increased publication number; (ii) doubling of peer-reviewed funding; (iii) doubling of NCI funding; and (iv) increase in number of multi-investigational grants from 1 to 5, which includes the NCI funded U54 SDSU-UCSD Cancer Center Comprehensive Partnership grant. In 2012, RCD investigators enrolled 831 individuals in intervention trials and 20,574 in observational studies. Importantly, the representation of racial/ethnic minorities in intervention studies is very high, with Hispanic/Latinos making up the majority. The RCD Program is the major entity targeting cancer research directly relevant to underserved and racial/ethnic minority populations in the MCC catchment area. The Cancer Center adds value to the RCD Program by providing shared resource facilities, pilot project grants, and recruitment of outstanding investigators.
The primary goal of the Reducing Cancer Disparities (RCD) Program is to develop and test the effectiveness of interventions to reduce cancer risk and modify behaviors among underserved populations in the MCC catchment area. RCD focuses on three specific areas: (i) lifestyle factors in community-based studies; (ii) tobacco cessation; and (iii) screening and early detection.
| Dow, Michelle; Pyke, Rachel M; Tsui, Brian Y et al. (2018) Integrative genomic analysis of mouse and human hepatocellular carcinoma. Proc Natl Acad Sci U S A 115:E9879-E9888 |
| Que, Xuchu; Hung, Ming-Yow; Yeang, Calvin et al. (2018) Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558:301-306 |
| Murzin, Vyacheslav L; Woods, Kaley; Moiseenko, Vitali et al. (2018) 4? plan optimization for cortical-sparing brain radiotherapy. Radiother Oncol 127:128-135 |
| Norton, Jeffrey A; Kim, Teresa; Kim, Joseph et al. (2018) SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors. J Gastrointest Surg 22:32-42 |
| Ikeda, Sadakatsu; Tsigelny, Igor F; Skjevik, Åge A et al. (2018) Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. Oncologist 23:586-593 |
| Buckley, Alexandra R; Ideker, Trey; Carter, Hannah et al. (2018) Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas. Genome Med 10:69 |
| Parish, Austin J; Nguyen, Vi; Goodman, Aaron M et al. (2018) GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers. Cancer 124:4080-4089 |
| Xu, Selene; Thompson, Wesley; Ancoli-Israel, Sonia et al. (2018) Cognition, quality-of-life, and symptom clusters in breast cancer: Using Bayesian networks to elucidate complex relationships. Psychooncology 27:802-809 |
| Tao, Li; Schwab, Richard B; San Miguel, Yazmin et al. (2018) Breast Cancer Mortality in Older and Younger Breast Cancer Patients in California. Cancer Epidemiol Biomarkers Prev : |
| Sagredo, Eduardo A; Blanco, Alejandro; Sagredo, Alfredo I et al. (2018) ADAR1-mediated RNA-editing of 3'UTRs in breast cancer. Biol Res 51:36 |
Showing the most recent 10 out of 862 publications
